Skip to main content

Table 2 Patient characteristics.

From: Image guided dose escalated prostate radiotherapy: still room to improve

Age  
Median (range) 71 Years (45 - 84)
Clinical T-category  
   T1b 1
   T1c 83 (T1 32%)
   T2a 125
   T2b 15 (T2 65%)
   T2c 28
   T3a 2
   T3b 2 (T3 2%)
   TX 3
Gleason score  
   5-6 96 (37%)
   7 141 (55%)
   8-10 21 (8%)
Initial PSA (ng/mL)  
Median (range) 7.6 (0.26-51.4)
Risk stratification  
   Low 59 (22%)
   Intermediate 163 (63%)
   High 37 (14%)
Radiotherapy Treatment  
   3-Dimensional Conformal 226 (87%)33
   IMRT (13%)